| 0 |
BASILAR ARTERY PERFORATION |
1 |
0.5000 |
| 1 |
ISCHAEMIC MITRAL REGURGITATION |
2 |
0.2500 |
| 2 |
OPHTHALMIC ARTERY OCCLUSION |
9 |
0.1552 |
| 3 |
VIRAL TONSILLITIS |
7 |
0.1250 |
| 4 |
CEREBROVASCULAR ARTERIOVENOUS MALFORMATION |
9 |
0.1034 |
| 5 |
ANEURYSM THROMBOSIS |
1 |
0.0769 |
| 6 |
CARDIAC VENTRICULAR SCARRING |
1 |
0.0667 |
| 7 |
FACTOR V INHIBITION |
10 |
0.0515 |
| 8 |
ANGINAL EQUIVALENT |
1 |
0.0500 |
| 9 |
CRUSH SYNDROME |
7 |
0.0496 |
| 10 |
OBSTRUCTIVE SHOCK |
5 |
0.0459 |
| 11 |
ALBINISM |
1 |
0.0435 |
| 12 |
PHAEOCHROMOCYTOMA CRISIS |
8 |
0.0377 |
| 13 |
VASCULAR STENT THROMBOSIS |
75 |
0.0368 |
| 14 |
SCROTAL HAEMATOMA |
3 |
0.0316 |
| 15 |
COAGULATION FACTOR V LEVEL DECREASED |
10 |
0.0307 |
| 16 |
MYOCARDIAL HAEMORRHAGE |
3 |
0.0273 |
| 17 |
VASCULAR STENT STENOSIS |
11 |
0.0261 |
| 18 |
REOCCLUSION |
2 |
0.0256 |
| 19 |
MYOCARDIAL CALCIFICATION |
3 |
0.0256 |
| 20 |
ARTERIAL INTRAMURAL HAEMATOMA |
2 |
0.0250 |
| 21 |
HEPARIN RESISTANCE |
3 |
0.0246 |
| 22 |
VASCULAR STENT OCCLUSION |
9 |
0.0223 |
| 23 |
OESOPHAGEAL INTRAMURAL HAEMATOMA |
2 |
0.0190 |
| 24 |
LIPID METABOLISM DISORDER |
7 |
0.0182 |
| 25 |
MEDIASTINAL HAEMATOMA |
3 |
0.0181 |
| 26 |
PLATELET FUNCTION TEST ABNORMAL |
4 |
0.0179 |
| 27 |
APNOEIC ATTACK |
10 |
0.0177 |
| 28 |
ACUTE RIGHT VENTRICULAR FAILURE |
3 |
0.0176 |
| 29 |
VASCULAR PSEUDOANEURYSM |
29 |
0.0166 |
| 30 |
CAROTID ARTERIOSCLEROSIS |
17 |
0.0165 |
| 31 |
VESSEL PERFORATION |
2 |
0.0152 |
| 32 |
CERVICOGENIC HEADACHE |
2 |
0.0147 |
| 33 |
PROSTATIC ABSCESS |
4 |
0.0145 |
| 34 |
CARDIAC PSEUDOANEURYSM |
1 |
0.0145 |
| 35 |
OCULAR RETROBULBAR HAEMORRHAGE |
2 |
0.0144 |
| 36 |
MYOCARDIAL STRAIN |
2 |
0.0144 |
| 37 |
DUODENITIS HAEMORRHAGIC |
2 |
0.0144 |
| 38 |
ATHEROSCLEROTIC PLAQUE RUPTURE |
1 |
0.0137 |
| 39 |
HYPERLIPASAEMIA |
7 |
0.0134 |
| 40 |
PHARYNGEAL NEOPLASM |
2 |
0.0129 |
| 41 |
ABDOMINAL SYMPTOM |
10 |
0.0124 |
| 42 |
BASILAR ARTERY THROMBOSIS |
2 |
0.0111 |
| 43 |
BRAIN STEM ISCHAEMIA |
2 |
0.0111 |
| 44 |
BRCA2 GENE MUTATION |
1 |
0.0105 |
| 45 |
ELECTROCARDIOGRAM QRS COMPLEX SHORTENED |
4 |
0.0104 |
| 46 |
SPINAL EPIDURAL HAEMATOMA |
6 |
0.0102 |
| 47 |
CORONARY ARTERY RESTENOSIS |
6 |
0.0100 |
| 48 |
BLADDER TAMPONADE |
3 |
0.0099 |
| 49 |
HAEMOBILIA |
4 |
0.0096 |
| 50 |
ADMINISTRATION SITE HAEMORRHAGE |
1 |
0.0096 |
| 51 |
LIPOPROTEIN (A) INCREASED |
3 |
0.0092 |
| 52 |
THROMBOLYSIS |
2 |
0.0090 |
| 53 |
CHRONIC CUTANEOUS LUPUS ERYTHEMATOSUS |
4 |
0.0089 |
| 54 |
ARTERIAL RESTENOSIS |
1 |
0.0085 |
| 55 |
AUTOIMMUNE HYPOTHYROIDISM |
2 |
0.0084 |
| 56 |
ARTERIOVENOUS FISTULA |
4 |
0.0081 |
| 57 |
ACETONAEMIA |
2 |
0.0079 |
| 58 |
AORTIC INTRAMURAL HAEMATOMA |
1 |
0.0077 |
| 59 |
DIABETIC METABOLIC DECOMPENSATION |
10 |
0.0072 |
| 60 |
HAEMORRHAGIC ASCITES |
2 |
0.0070 |
| 61 |
ANASTOMOTIC ULCER HAEMORRHAGE |
1 |
0.0070 |
| 62 |
HYPOURICAEMIA |
2 |
0.0069 |
| 63 |
ACCELERATED IDIOVENTRICULAR RHYTHM |
1 |
0.0068 |
| 64 |
INTRAVENTRICULAR HAEMORRHAGE |
16 |
0.0064 |
| 65 |
PROTHROMBIN TIME SHORTENED |
9 |
0.0064 |
| 66 |
OESOPHAGEAL CANCER METASTATIC |
2 |
0.0063 |
| 67 |
BONE FISTULA |
1 |
0.0063 |
| 68 |
LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR |
54 |
0.0061 |
| 69 |
IMMUNE-MEDIATED THYROIDITIS |
3 |
0.0061 |
| 70 |
CAROTID ARTERY ANEURYSM |
2 |
0.0058 |
| 71 |
THROMBOSIS IN DEVICE |
19 |
0.0058 |
| 72 |
CEREBELLAR HAEMORRHAGE |
8 |
0.0056 |
| 73 |
HYPOTHALAMIC PITUITARY ADRENAL AXIS SUPPRESSION |
2 |
0.0056 |
| 74 |
CHRONIC LEFT VENTRICULAR FAILURE |
2 |
0.0056 |
| 75 |
TONIC CLONIC MOVEMENTS |
7 |
0.0054 |
| 76 |
HAEMORRHAGIC ARTERIOVENOUS MALFORMATION |
5 |
0.0053 |
| 77 |
ARTERIOVENOUS FISTULA SITE HAEMORRHAGE |
1 |
0.0053 |
| 78 |
INTRACRANIAL HAEMATOMA |
3 |
0.0053 |
| 79 |
GALLBLADDER PERFORATION |
2 |
0.0052 |
| 80 |
ATONIC URINARY BLADDER |
1 |
0.0052 |
| 81 |
PERIPHERAL ARTERIAL OCCLUSIVE DISEASE |
21 |
0.0051 |
| 82 |
ACQUIRED HAEMOPHILIA |
5 |
0.0050 |
| 83 |
VASCULAR OPERATION |
2 |
0.0050 |
| 84 |
CORONARY ARTERY THROMBOSIS |
10 |
0.0050 |
| 85 |
LICHENIFICATION |
2 |
0.0049 |
| 86 |
ARTERY DISSECTION |
2 |
0.0048 |
| 87 |
URINARY BLADDER HAEMORRHAGE |
10 |
0.0047 |
| 88 |
AUTOINFLAMMATORY DISEASE |
1 |
0.0047 |
| 89 |
OESOPHAGEAL DILATATION |
2 |
0.0045 |
| 90 |
CORONARY ARTERY STENOSIS |
22 |
0.0044 |
| 91 |
CARDIAC PERFORATION |
1 |
0.0043 |
| 92 |
METASTASES TO ADRENALS |
4 |
0.0043 |
| 93 |
URINARY TRACT INFECTION ENTEROCOCCAL |
4 |
0.0043 |
| 94 |
PUNCTURE SITE HAEMORRHAGE |
3 |
0.0042 |
| 95 |
CRANIAL NERVE PARALYSIS |
2 |
0.0042 |
| 96 |
ARRESTED LABOUR |
1 |
0.0042 |
| 97 |
BLOOD IMMUNOGLOBULIN E INCREASED |
10 |
0.0041 |
| 98 |
PERICARDIAL HAEMORRHAGE |
9 |
0.0041 |
| 99 |
CEREBRAL VASOCONSTRICTION |
3 |
0.0041 |
| 100 |
DERMATOMYOSITIS |
10 |
0.0039 |
| 101 |
ADAMTS13 ACTIVITY DECREASED |
1 |
0.0039 |
| 102 |
BRONCHIAL CARCINOMA |
3 |
0.0038 |
| 103 |
BRAIN MIDLINE SHIFT |
2 |
0.0038 |
| 104 |
ARTERIOVENOUS FISTULA OPERATION |
1 |
0.0037 |
| 105 |
ARTERIAL STENT INSERTION |
1 |
0.0037 |
| 106 |
ACUTE MYOCARDIAL INFARCTION |
108 |
0.0037 |
| 107 |
IMMUNE-MEDIATED MYOSITIS |
10 |
0.0036 |
| 108 |
POTENTIATING DRUG INTERACTION |
12 |
0.0036 |
| 109 |
ARTERIAL HAEMORRHAGE |
4 |
0.0035 |
| 110 |
THERAPEUTIC PRODUCT CROSS-REACTIVITY |
3 |
0.0034 |
| 111 |
CREPITATIONS |
10 |
0.0034 |
| 112 |
HAEMATOMA MUSCLE |
4 |
0.0033 |
| 113 |
ELECTROCARDIOGRAM ST SEGMENT ELEVATION |
11 |
0.0033 |
| 114 |
CARDIAC DEATH |
4 |
0.0033 |
| 115 |
GASTROINTESTINAL POLYP HAEMORRHAGE |
2 |
0.0033 |
| 116 |
ANEURYSM |
16 |
0.0032 |
| 117 |
BRONCHIAL HAEMORRHAGE |
1 |
0.0032 |
| 118 |
BED REST |
1 |
0.0032 |
| 119 |
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME |
12 |
0.0031 |
| 120 |
DIVERTICULUM INTESTINAL HAEMORRHAGIC |
7 |
0.0031 |
| 121 |
HYPOCOAGULABLE STATE |
3 |
0.0031 |
| 122 |
LISTLESS |
10 |
0.0030 |
| 123 |
PHAEOCHROMOCYTOMA |
2 |
0.0030 |
| 124 |
POST PROCEDURAL SEPSIS |
2 |
0.0030 |
| 125 |
ACUTE LEFT VENTRICULAR FAILURE |
2 |
0.0030 |
| 126 |
DIABETIC RETINOPATHY |
10 |
0.0029 |
| 127 |
ASTHMA EXERCISE INDUCED |
1 |
0.0029 |
| 128 |
PEPTIC ULCER HAEMORRHAGE |
2 |
0.0029 |
| 129 |
N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED |
4 |
0.0028 |
| 130 |
FALSE NEGATIVE INVESTIGATION RESULT |
2 |
0.0028 |
| 131 |
RETROPERITONEAL HAEMORRHAGE |
7 |
0.0028 |
| 132 |
HYPERTENSIVE NEPHROPATHY |
3 |
0.0028 |
| 133 |
TACHYARRHYTHMIA |
7 |
0.0028 |
| 134 |
HAEMORRHAGIC DISORDER |
3 |
0.0028 |
| 135 |
HAEMOTHORAX |
8 |
0.0028 |
| 136 |
MYOPATHY |
23 |
0.0027 |
| 137 |
MIXED LIVER INJURY |
8 |
0.0027 |
| 138 |
KOUNIS SYNDROME |
6 |
0.0026 |
| 139 |
ATRIOVENTRICULAR BLOCK SECOND DEGREE |
8 |
0.0026 |
| 140 |
CORONARY ARTERY OCCLUSION |
36 |
0.0026 |
| 141 |
COAGULATION TEST ABNORMAL |
2 |
0.0026 |
| 142 |
MUSCLE RUPTURE |
10 |
0.0026 |
| 143 |
HYPOVOLAEMIC SHOCK |
12 |
0.0025 |
| 144 |
HAEMOPERITONEUM |
2 |
0.0025 |
| 145 |
TUMOUR EXCISION |
2 |
0.0025 |
| 146 |
IRON DEFICIENCY |
11 |
0.0024 |
| 147 |
POLYCYTHAEMIA VERA |
2 |
0.0024 |
| 148 |
PHARYNGEAL HAEMORRHAGE |
3 |
0.0024 |
| 149 |
AORTIC OCCLUSION |
1 |
0.0024 |
| 150 |
CARDIAC VENTRICULAR DISORDER |
1 |
0.0024 |
| 151 |
INTRA-ABDOMINAL HAEMATOMA |
3 |
0.0024 |
| 152 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED |
12 |
0.0024 |
| 153 |
GASTRIC ULCER PERFORATION |
3 |
0.0024 |
| 154 |
PYLORIC STENOSIS |
2 |
0.0024 |
| 155 |
CAROTID ARTERY THROMBOSIS |
2 |
0.0024 |
| 156 |
ANAL SPHINCTER ATONY |
1 |
0.0023 |
| 157 |
CARDIAC VENTRICULAR THROMBOSIS |
3 |
0.0023 |
| 158 |
ARTERIAL STENOSIS |
2 |
0.0023 |
| 159 |
SHOCK HAEMORRHAGIC |
18 |
0.0022 |
| 160 |
PERIPHERAL ISCHAEMIA |
9 |
0.0022 |
| 161 |
ATYPICAL MYCOBACTERIAL INFECTION |
3 |
0.0021 |
| 162 |
LOW DENSITY LIPOPROTEIN DECREASED |
3 |
0.0021 |
| 163 |
INTRA-ABDOMINAL HAEMORRHAGE |
5 |
0.0021 |
| 164 |
DUODENAL ULCER HAEMORRHAGE |
6 |
0.0021 |
| 165 |
LABELLED DRUG-DRUG INTERACTION ISSUE |
3 |
0.0021 |
| 166 |
PHOTOPSIA |
13 |
0.0021 |
| 167 |
BREATH SOUNDS ABNORMAL |
10 |
0.0020 |
| 168 |
HIGH DENSITY LIPOPROTEIN INCREASED |
2 |
0.0020 |
| 169 |
PRINZMETAL ANGINA |
2 |
0.0020 |
| 170 |
HAEMORRHAGIC TRANSFORMATION STROKE |
3 |
0.0020 |
| 171 |
STENT PLACEMENT |
16 |
0.0020 |
| 172 |
ILEAL ULCER |
2 |
0.0020 |
| 173 |
BRAIN STEM INFARCTION |
2 |
0.0020 |
| 174 |
ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC |
3 |
0.0020 |
| 175 |
COAGULATION TIME PROLONGED |
3 |
0.0019 |
| 176 |
URETEROLITHIASIS |
2 |
0.0019 |
| 177 |
INFARCTION |
13 |
0.0019 |
| 178 |
SYSTOLIC DYSFUNCTION |
2 |
0.0019 |
| 179 |
INTERMITTENT CLAUDICATION |
3 |
0.0019 |
| 180 |
CARDIOGENIC SHOCK |
27 |
0.0019 |
| 181 |
CEREBRAL ARTERY OCCLUSION |
2 |
0.0019 |
| 182 |
CLAUSTROPHOBIA |
2 |
0.0018 |
| 183 |
RETROPERITONEAL HAEMATOMA |
4 |
0.0018 |
| 184 |
GASTRIC ULCER HAEMORRHAGE |
10 |
0.0018 |
| 185 |
GASTROINTESTINAL ULCER HAEMORRHAGE |
2 |
0.0018 |
| 186 |
PUPIL FIXED |
3 |
0.0017 |
| 187 |
SPINAL CORD INJURY |
3 |
0.0017 |
| 188 |
THROMBOTIC THROMBOCYTOPENIC PURPURA |
6 |
0.0017 |
| 189 |
HAEMATOMA |
44 |
0.0017 |
| 190 |
ANGINA UNSTABLE |
11 |
0.0017 |
| 191 |
CORONARY ARTERY DISEASE |
51 |
0.0017 |
| 192 |
CARDIAC TAMPONADE |
8 |
0.0017 |
| 193 |
PROTHROMBIN TIME PROLONGED |
10 |
0.0017 |
| 194 |
CARDIAC PROCEDURE COMPLICATION |
1 |
0.0016 |
| 195 |
ATRIAL FLUTTER |
13 |
0.0016 |
| 196 |
HAEMORRHAGIC ANAEMIA |
7 |
0.0016 |
| 197 |
HYPOMAGNESAEMIA |
22 |
0.0016 |
| 198 |
CORONARY ARTERIAL STENT INSERTION |
8 |
0.0016 |
| 199 |
SUBARACHNOID HAEMORRHAGE |
16 |
0.0016 |
| 200 |
ARTERIAL DISORDER |
3 |
0.0016 |
| 201 |
ACUTE CORONARY SYNDROME |
13 |
0.0016 |
| 202 |
BLOOD CREATINE PHOSPHOKINASE MB INCREASED |
2 |
0.0016 |
| 203 |
NOCARDIOSIS |
4 |
0.0016 |
| 204 |
DRUG RESISTANCE |
40 |
0.0016 |
| 205 |
LIBIDO DISORDER |
2 |
0.0015 |
| 206 |
PROCEDURAL HAEMORRHAGE |
6 |
0.0015 |
| 207 |
ARTERIOSPASM CORONARY |
6 |
0.0015 |
| 208 |
RENAL HAEMORRHAGE |
3 |
0.0015 |
| 209 |
ISCHAEMIC HEPATITIS |
2 |
0.0015 |
| 210 |
AKINESIA |
3 |
0.0014 |
| 211 |
ANAL HAEMORRHAGE |
4 |
0.0014 |
| 212 |
PERIPHERAL ARTERY OCCLUSION |
2 |
0.0014 |
| 213 |
ARTERIAL OCCLUSIVE DISEASE |
11 |
0.0014 |
| 214 |
CAROTID ARTERY OCCLUSION |
5 |
0.0014 |
| 215 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
23 |
0.0014 |
| 216 |
AORTIC VALVE SCLEROSIS |
1 |
0.0014 |
| 217 |
ACUTE ABDOMEN |
2 |
0.0014 |
| 218 |
MELAENA |
30 |
0.0014 |
| 219 |
VENTRICULAR EXTRASYSTOLES |
14 |
0.0013 |
| 220 |
GASTRITIS HAEMORRHAGIC |
2 |
0.0013 |
| 221 |
GASTROINTESTINAL HYPOMOTILITY |
3 |
0.0013 |
| 222 |
SECONDARY ADRENOCORTICAL INSUFFICIENCY |
2 |
0.0013 |
| 223 |
BLOOD LOSS ANAEMIA |
3 |
0.0013 |
| 224 |
ELECTROCARDIOGRAM T WAVE ABNORMAL |
2 |
0.0013 |
| 225 |
CONTRAST MEDIA REACTION |
3 |
0.0013 |
| 226 |
POLYMYALGIA RHEUMATICA |
4 |
0.0013 |
| 227 |
PULMONARY ALVEOLAR HAEMORRHAGE |
7 |
0.0012 |
| 228 |
AORTIC VALVE DISEASE |
2 |
0.0012 |
| 229 |
LOWER GASTROINTESTINAL HAEMORRHAGE |
9 |
0.0012 |
| 230 |
RESUSCITATION |
2 |
0.0012 |
| 231 |
CARDIAC STRESS TEST ABNORMAL |
1 |
0.0012 |
| 232 |
TROPONIN I INCREASED |
2 |
0.0012 |
| 233 |
HYPERPARATHYROIDISM SECONDARY |
3 |
0.0012 |
| 234 |
CEREBRAL HAEMATOMA |
4 |
0.0012 |
| 235 |
RHABDOMYOLYSIS |
49 |
0.0012 |
| 236 |
HYPOCALCAEMIA |
22 |
0.0012 |
| 237 |
TYPE 1 DIABETES MELLITUS |
7 |
0.0012 |
| 238 |
MYCOBACTERIAL INFECTION |
2 |
0.0012 |
| 239 |
HAEMORRHAGE INTRACRANIAL |
17 |
0.0011 |
| 240 |
CATHETERISATION CARDIAC |
5 |
0.0011 |
| 241 |
ESSENTIAL HYPERTENSION |
2 |
0.0011 |
| 242 |
ANEURYSM RUPTURED |
1 |
0.0011 |
| 243 |
PARADOXICAL DRUG REACTION |
4 |
0.0011 |
| 244 |
OPPORTUNISTIC INFECTION |
2 |
0.0011 |
| 245 |
NEPHROGENIC ANAEMIA |
5 |
0.0011 |
| 246 |
OBSTRUCTIVE AIRWAYS DISORDER |
12 |
0.0011 |
| 247 |
GASTRITIS EROSIVE |
5 |
0.0011 |
| 248 |
BLOOD IRON INCREASED |
2 |
0.0011 |
| 249 |
EYE HAEMORRHAGE |
14 |
0.0010 |
| 250 |
COMA SCALE ABNORMAL |
3 |
0.0010 |
| 251 |
BLOOD PARATHYROID HORMONE INCREASED |
3 |
0.0010 |
| 252 |
ABDOMINAL WALL HAEMATOMA |
2 |
0.0010 |
| 253 |
HYPOGEUSIA |
2 |
0.0010 |
| 254 |
MYOCARDIAL INFARCTION |
177 |
0.0010 |
| 255 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
26 |
0.0010 |
| 256 |
CARDIAC ANEURYSM |
1 |
0.0010 |
| 257 |
IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME |
5 |
0.0010 |
| 258 |
SMALL INTESTINAL HAEMORRHAGE |
2 |
0.0010 |
| 259 |
ISCHAEMIC CARDIOMYOPATHY |
3 |
0.0010 |
| 260 |
POLYURIA |
8 |
0.0010 |
| 261 |
ATRIAL THROMBOSIS |
2 |
0.0010 |
| 262 |
CHEST INJURY |
2 |
0.0010 |
| 263 |
ARTERIOSCLEROSIS |
9 |
0.0010 |
| 264 |
GINGIVAL BLEEDING |
13 |
0.0010 |
| 265 |
CEREBRAL HAEMORRHAGE |
34 |
0.0009 |
| 266 |
SLEEP APNOEA SYNDROME |
18 |
0.0009 |
| 267 |
CARDIAC FAILURE CHRONIC |
4 |
0.0009 |
| 268 |
VENTRICULAR HYPOKINESIA |
3 |
0.0009 |
| 269 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
8 |
0.0009 |
| 270 |
DIABETIC KETOACIDOSIS |
22 |
0.0009 |
| 271 |
ELECTROCARDIOGRAM ST SEGMENT DEPRESSION |
2 |
0.0009 |
| 272 |
SUBDURAL HAEMATOMA |
13 |
0.0009 |
| 273 |
COLONOSCOPY |
2 |
0.0009 |
| 274 |
ANGINA PECTORIS |
26 |
0.0009 |
| 275 |
EJECTION FRACTION DECREASED |
14 |
0.0009 |
| 276 |
ATRIOVENTRICULAR BLOCK COMPLETE |
6 |
0.0009 |
| 277 |
SUDDEN CARDIAC DEATH |
3 |
0.0009 |
| 278 |
MYOCARDIAL ISCHAEMIA |
10 |
0.0009 |
| 279 |
ADMINISTRATION SITE PAIN |
1 |
0.0009 |
| 280 |
AORTIC THROMBOSIS |
1 |
0.0009 |
| 281 |
DERMATITIS EXFOLIATIVE GENERALISED |
3 |
0.0009 |
| 282 |
CAROTID ARTERY STENOSIS |
3 |
0.0009 |
| 283 |
DIPLOPIA |
22 |
0.0008 |
| 284 |
BLEEDING TIME PROLONGED |
1 |
0.0008 |
| 285 |
PRODUCT PACKAGING CONFUSION |
2 |
0.0008 |
| 286 |
THROMBOCYTOSIS |
3 |
0.0008 |
| 287 |
DRUG ADMINISTRATION ERROR |
25 |
0.0008 |
| 288 |
WOUND HAEMORRHAGE |
3 |
0.0008 |
| 289 |
CARTILAGE INJURY |
2 |
0.0008 |
| 290 |
HYPERCALCAEMIA |
10 |
0.0008 |
| 291 |
FEELING DRUNK |
6 |
0.0008 |
| 292 |
HEPATIC STEATOSIS |
15 |
0.0008 |
| 293 |
RETINOPATHY |
3 |
0.0008 |
| 294 |
EPISTAXIS |
60 |
0.0008 |
| 295 |
PLATELET DISORDER |
2 |
0.0008 |
| 296 |
INTERNAL HAEMORRHAGE |
9 |
0.0008 |
| 297 |
CONJUNCTIVAL HAEMORRHAGE |
3 |
0.0008 |
| 298 |
GASTRIC HAEMORRHAGE |
9 |
0.0008 |
| 299 |
OESOPHAGEAL DISORDER |
3 |
0.0008 |
| 300 |
GASTROINTESTINAL HAEMORRHAGE |
65 |
0.0008 |
| 301 |
LOW DENSITY LIPOPROTEIN INCREASED |
6 |
0.0008 |
| 302 |
HEPATITIS ACUTE |
5 |
0.0008 |
| 303 |
RENAL CYST |
6 |
0.0008 |
| 304 |
ANION GAP INCREASED |
1 |
0.0007 |
| 305 |
LEFT VENTRICULAR DYSFUNCTION |
5 |
0.0007 |
| 306 |
ORGAN FAILURE |
3 |
0.0007 |
| 307 |
SHOULDER ARTHROPLASTY |
2 |
0.0007 |
| 308 |
B-LYMPHOCYTE COUNT DECREASED |
1 |
0.0007 |
| 309 |
PROSTATIC SPECIFIC ANTIGEN INCREASED |
10 |
0.0007 |
| 310 |
HYPERCHOLESTEROLAEMIA |
7 |
0.0007 |
| 311 |
VITREOUS HAEMORRHAGE |
2 |
0.0007 |
| 312 |
BLOOD TEST ABNORMAL |
10 |
0.0007 |
| 313 |
AORTIC VALVE INCOMPETENCE |
3 |
0.0007 |
| 314 |
INTERVERTEBRAL DISC DISORDER |
3 |
0.0007 |
| 315 |
DRUG-INDUCED LIVER INJURY |
22 |
0.0007 |
| 316 |
TUMOUR HAEMORRHAGE |
2 |
0.0007 |
| 317 |
DRUG INTERACTION |
111 |
0.0007 |
| 318 |
BLADDER TRANSITIONAL CELL CARCINOMA |
1 |
0.0007 |
| 319 |
PARAPLEGIA |
2 |
0.0007 |
| 320 |
ATRIOVENTRICULAR BLOCK FIRST DEGREE |
3 |
0.0007 |
| 321 |
MONOPLEGIA |
3 |
0.0007 |
| 322 |
DYSPNOEA AT REST |
2 |
0.0007 |
| 323 |
LIVER FUNCTION TEST ABNORMAL |
20 |
0.0007 |
| 324 |
BILIARY COLIC |
2 |
0.0007 |
| 325 |
GASTROINTESTINAL NECROSIS |
2 |
0.0007 |
| 326 |
PULMONARY PAIN |
2 |
0.0007 |
| 327 |
HYPERCHLORHYDRIA |
4 |
0.0007 |
| 328 |
HAEMATURIA |
23 |
0.0007 |
| 329 |
ANGIOPLASTY |
1 |
0.0007 |
| 330 |
NORMOCHROMIC NORMOCYTIC ANAEMIA |
2 |
0.0007 |
| 331 |
REBOUND ACID HYPERSECRETION |
2 |
0.0007 |
| 332 |
THROMBOPHLEBITIS SUPERFICIAL |
2 |
0.0007 |
| 333 |
IMMUNE THROMBOCYTOPENIA |
3 |
0.0007 |
| 334 |
DUODENITIS |
2 |
0.0007 |
| 335 |
INTRACARDIAC THROMBUS |
2 |
0.0007 |
| 336 |
DIASTOLIC DYSFUNCTION |
2 |
0.0006 |
| 337 |
MULTIPLE-DRUG RESISTANCE |
2 |
0.0006 |
| 338 |
HAEMORRHAGIC STROKE |
5 |
0.0006 |
| 339 |
SUSPECTED SUICIDE |
3 |
0.0006 |
| 340 |
NON-CARDIAC CHEST PAIN |
2 |
0.0006 |
| 341 |
VENTRICULAR FIBRILLATION |
7 |
0.0006 |
| 342 |
TRICUSPID VALVE INCOMPETENCE |
5 |
0.0006 |
| 343 |
LACTIC ACIDOSIS |
20 |
0.0006 |
| 344 |
VITAMIN D DEFICIENCY |
6 |
0.0006 |
| 345 |
CARDIOVASCULAR INSUFFICIENCY |
1 |
0.0006 |
| 346 |
HEPARIN-INDUCED THROMBOCYTOPENIA |
3 |
0.0006 |
| 347 |
BRADYARRHYTHMIA |
1 |
0.0006 |
| 348 |
DIABETIC NEUROPATHY |
3 |
0.0006 |
| 349 |
CYTOLYTIC HEPATITIS |
2 |
0.0006 |
| 350 |
LYME DISEASE |
2 |
0.0006 |
| 351 |
PNEUMONITIS |
16 |
0.0006 |
| 352 |
IMPAIRED GASTRIC EMPTYING |
8 |
0.0006 |
| 353 |
ECCHYMOSIS |
4 |
0.0006 |
| 354 |
PETECHIAE |
6 |
0.0006 |
| 355 |
AORTIC STENOSIS |
2 |
0.0006 |
| 356 |
PARTIAL SEIZURES |
3 |
0.0006 |
| 357 |
OBESITY |
9 |
0.0006 |
| 358 |
HAEMORRHAGE SUBCUTANEOUS |
2 |
0.0006 |
| 359 |
HAEMORRHAGE |
58 |
0.0006 |
| 360 |
OROPHARYNGEAL DISCOMFORT |
5 |
0.0006 |
| 361 |
BLOOD PRESSURE ABNORMAL |
11 |
0.0006 |
| 362 |
HAEMATEMESIS |
14 |
0.0006 |
| 363 |
HEPATIC CYTOLYSIS |
7 |
0.0005 |
| 364 |
HYPERKERATOSIS |
3 |
0.0005 |
| 365 |
INCREASED TENDENCY TO BRUISE |
5 |
0.0005 |
| 366 |
HAEMOPTYSIS |
15 |
0.0005 |
| 367 |
CARDIAC DYSFUNCTION |
2 |
0.0005 |
| 368 |
BLOOD CHOLESTEROL DECREASED |
1 |
0.0005 |
| 369 |
RECTAL HAEMORRHAGE |
23 |
0.0005 |
| 370 |
ACUTE PULMONARY OEDEMA |
3 |
0.0005 |
| 371 |
MITRAL VALVE INCOMPETENCE |
6 |
0.0005 |
| 372 |
BLOOD BICARBONATE DECREASED |
1 |
0.0005 |
| 373 |
BILE DUCT OBSTRUCTION |
1 |
0.0005 |
| 374 |
TROPONIN INCREASED |
4 |
0.0005 |
| 375 |
HAEMODYNAMIC INSTABILITY |
4 |
0.0005 |
| 376 |
GASTRIC INFECTION |
2 |
0.0005 |
| 377 |
SUPRAVENTRICULAR TACHYCARDIA |
5 |
0.0005 |
| 378 |
DRUG PRESCRIBING ERROR |
10 |
0.0005 |
| 379 |
CHEST PAIN |
96 |
0.0005 |
| 380 |
ARTERIAL THROMBOSIS |
1 |
0.0005 |
| 381 |
THERAPEUTIC PRODUCT INEFFECTIVE |
2 |
0.0005 |
| 382 |
SINUS BRADYCARDIA |
5 |
0.0005 |
| 383 |
CARCINOEMBRYONIC ANTIGEN INCREASED |
1 |
0.0005 |
| 384 |
POST PROCEDURAL HAEMORRHAGE |
6 |
0.0005 |
| 385 |
PRODUCT LABEL CONFUSION |
3 |
0.0005 |
| 386 |
ALCOHOL INTERACTION |
1 |
0.0005 |
| 387 |
PERIPHERAL SENSORY NEUROPATHY |
3 |
0.0005 |
| 388 |
ORAL INFECTION |
2 |
0.0005 |
| 389 |
OESOPHAGEAL PAIN |
2 |
0.0005 |
| 390 |
ACCIDENT |
6 |
0.0005 |
| 391 |
ALLERGIC REACTION TO EXCIPIENT |
1 |
0.0005 |
| 392 |
SKIN PAPILLOMA |
2 |
0.0005 |
| 393 |
MUSCLE HAEMORRHAGE |
2 |
0.0005 |
| 394 |
DEVICE OCCLUSION |
7 |
0.0005 |
| 395 |
TOXIC SKIN ERUPTION |
5 |
0.0005 |
| 396 |
HYPOGLYCAEMIA |
24 |
0.0005 |
| 397 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
14 |
0.0005 |
| 398 |
VITAMIN B12 DEFICIENCY |
2 |
0.0005 |
| 399 |
VENTRICULAR TACHYCARDIA |
8 |
0.0005 |
| 400 |
ADJUSTMENT DISORDER WITH DEPRESSED MOOD |
1 |
0.0005 |
| 401 |
COAGULOPATHY |
8 |
0.0005 |
| 402 |
MUSCLE FATIGUE |
2 |
0.0005 |
| 403 |
BUNDLE BRANCH BLOCK LEFT |
2 |
0.0005 |
| 404 |
ACUTE RESPIRATORY FAILURE |
9 |
0.0005 |
| 405 |
LEFT VENTRICULAR HYPERTROPHY |
2 |
0.0005 |
| 406 |
THROMBOSIS |
37 |
0.0005 |
| 407 |
POLYP |
3 |
0.0005 |
| 408 |
URINE OUTPUT DECREASED |
4 |
0.0005 |
| 409 |
DIVERTICULUM INTESTINAL |
2 |
0.0005 |
| 410 |
PHARYNGEAL OEDEMA |
7 |
0.0005 |
| 411 |
CARDIAC FAILURE ACUTE |
3 |
0.0004 |
| 412 |
RHINITIS ALLERGIC |
2 |
0.0004 |
| 413 |
MYOSITIS |
4 |
0.0004 |
| 414 |
ELECTROCARDIOGRAM QT PROLONGED |
16 |
0.0004 |
| 415 |
ULCER HAEMORRHAGE |
3 |
0.0004 |
| 416 |
END STAGE RENAL DISEASE |
8 |
0.0004 |
| 417 |
BUNDLE BRANCH BLOCK RIGHT |
2 |
0.0004 |
| 418 |
ISCHAEMIA |
2 |
0.0004 |
| 419 |
ACUTE FEBRILE NEUTROPHILIC DERMATOSIS |
1 |
0.0004 |
| 420 |
HYPERKALAEMIA |
15 |
0.0004 |
| 421 |
DRUG LEVEL INCREASED |
7 |
0.0004 |
| 422 |
MEDICATION RESIDUE PRESENT |
2 |
0.0004 |
| 423 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
12 |
0.0004 |
| 424 |
PRESYNCOPE |
10 |
0.0004 |
| 425 |
LABORATORY TEST ABNORMAL |
12 |
0.0004 |
| 426 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
21 |
0.0004 |
| 427 |
INJECTION SITE INFLAMMATION |
2 |
0.0004 |
| 428 |
HYPERNATRAEMIA |
2 |
0.0004 |
| 429 |
BRADYCARDIA |
21 |
0.0004 |
| 430 |
BRAIN OEDEMA |
5 |
0.0004 |
| 431 |
AMMONIA INCREASED |
2 |
0.0004 |
| 432 |
INCORRECT ROUTE OF DRUG ADMINISTRATION |
14 |
0.0004 |
| 433 |
ATRIOVENTRICULAR BLOCK |
3 |
0.0004 |
| 434 |
TYPE 2 DIABETES MELLITUS |
13 |
0.0004 |
| 435 |
ACTINIC KERATOSIS |
1 |
0.0004 |
| 436 |
PULMONARY HAEMORRHAGE |
3 |
0.0004 |
| 437 |
MALABSORPTION |
2 |
0.0004 |
| 438 |
GASTROINTESTINAL INFLAMMATION |
3 |
0.0004 |
| 439 |
ELECTROCARDIOGRAM ABNORMAL |
3 |
0.0004 |
| 440 |
TRANSFUSION |
4 |
0.0004 |
| 441 |
MYALGIA |
64 |
0.0004 |
| 442 |
ANIMAL BITE |
1 |
0.0004 |
| 443 |
AREFLEXIA |
1 |
0.0004 |
| 444 |
OVERWEIGHT |
2 |
0.0004 |
| 445 |
OEDEMA |
20 |
0.0004 |
| 446 |
BLOOD URINE PRESENT |
7 |
0.0004 |
| 447 |
ABDOMINAL RIGIDITY |
1 |
0.0004 |
| 448 |
HYDROCEPHALUS |
2 |
0.0004 |
| 449 |
CHOLESTASIS |
7 |
0.0004 |
| 450 |
TRANSIENT ISCHAEMIC ATTACK |
12 |
0.0004 |
| 451 |
HEMIPARESIS |
6 |
0.0004 |
| 452 |
ACUTE LYMPHOCYTIC LEUKAEMIA |
1 |
0.0004 |
| 453 |
ACUTE KIDNEY INJURY |
54 |
0.0004 |
| 454 |
HEPATOCELLULAR INJURY |
5 |
0.0004 |
| 455 |
DISTURBANCE IN ATTENTION |
19 |
0.0004 |
| 456 |
IMPAIRED DRIVING ABILITY |
4 |
0.0004 |
| 457 |
VITAMIN D DECREASED |
3 |
0.0004 |
| 458 |
CARDIAC VALVE DISEASE |
2 |
0.0003 |
| 459 |
CARDIAC OPERATION |
3 |
0.0003 |
| 460 |
CORONARY ARTERY BYPASS |
2 |
0.0003 |
| 461 |
IMPAIRED QUALITY OF LIFE |
5 |
0.0003 |
| 462 |
SEPTIC SHOCK |
15 |
0.0003 |
| 463 |
HYPOKINESIA |
5 |
0.0003 |
| 464 |
HAEMATOCHEZIA |
19 |
0.0003 |
| 465 |
STRESS CARDIOMYOPATHY |
2 |
0.0003 |
| 466 |
AUTONOMIC NERVOUS SYSTEM IMBALANCE |
1 |
0.0003 |
| 467 |
PRODUCT COMMUNICATION ISSUE |
3 |
0.0003 |
| 468 |
CARDIOMYOPATHY |
5 |
0.0003 |
| 469 |
ISCHAEMIC STROKE |
6 |
0.0003 |
| 470 |
PULMONARY OEDEMA |
15 |
0.0003 |
| 471 |
BRAIN HERNIATION |
1 |
0.0003 |
| 472 |
HYPERLIPIDAEMIA |
4 |
0.0003 |
| 473 |
JAUNDICE |
9 |
0.0003 |
| 474 |
ANAL INCONTINENCE |
3 |
0.0003 |
| 475 |
BONE MARROW DISORDER |
1 |
0.0003 |
| 476 |
CONTRAINDICATED PRODUCT ADMINISTERED |
10 |
0.0003 |
| 477 |
PANIC ATTACK |
12 |
0.0003 |
| 478 |
FIBROMYALGIA |
8 |
0.0003 |
| 479 |
TREATMENT NONCOMPLIANCE |
18 |
0.0003 |
| 480 |
INGUINAL HERNIA |
2 |
0.0003 |
| 481 |
GLOMERULAR FILTRATION RATE DECREASED |
4 |
0.0003 |
| 482 |
UROSEPSIS |
3 |
0.0003 |
| 483 |
BRAIN NATRIURETIC PEPTIDE INCREASED |
1 |
0.0003 |
| 484 |
BRAIN DEATH |
1 |
0.0003 |
| 485 |
HEPATIC ENCEPHALOPATHY |
3 |
0.0003 |
| 486 |
AGEUSIA |
8 |
0.0003 |
| 487 |
SWELLING OF EYELID |
2 |
0.0003 |
| 488 |
DERMATITIS ALLERGIC |
4 |
0.0003 |
| 489 |
CARDIAC ARREST |
26 |
0.0003 |
| 490 |
BILE DUCT STONE |
1 |
0.0003 |
| 491 |
HEPATOTOXICITY |
7 |
0.0003 |
| 492 |
VERTIGO |
19 |
0.0003 |
| 493 |
HAEMOGLOBIN ABNORMAL |
2 |
0.0003 |
| 494 |
HYPERHIDROSIS |
40 |
0.0003 |
| 495 |
UNRESPONSIVE TO STIMULI |
8 |
0.0003 |
| 496 |
COELIAC DISEASE |
3 |
0.0003 |
| 497 |
SOMNAMBULISM |
2 |
0.0003 |
| 498 |
CHRONIC KIDNEY DISEASE |
23 |
0.0003 |
| 499 |
ARTERIOSCLEROSIS CORONARY ARTERY |
2 |
0.0003 |
| 500 |
CARDIAC FAILURE |
24 |
0.0003 |
| 501 |
PRODUCT ADMINISTRATION ERROR |
6 |
0.0003 |
| 502 |
BLOOD BILIRUBIN INCREASED |
8 |
0.0003 |
| 503 |
PRODUCT LABEL ISSUE |
2 |
0.0003 |
| 504 |
HEPATIC FUNCTION ABNORMAL |
11 |
0.0003 |
| 505 |
PRODUCT PRESCRIBING ERROR |
7 |
0.0003 |
| 506 |
ANGIOEDEMA |
13 |
0.0003 |
| 507 |
CIRCULATORY COLLAPSE |
5 |
0.0003 |
| 508 |
CHEST DISCOMFORT |
30 |
0.0003 |
| 509 |
CONTUSION |
28 |
0.0003 |
| 510 |
HYPERBILIRUBINAEMIA |
3 |
0.0003 |
| 511 |
BLOOD CREATININE ABNORMAL |
1 |
0.0003 |
| 512 |
LARGE INTESTINE POLYP |
2 |
0.0003 |
| 513 |
MENTAL STATUS CHANGES |
8 |
0.0003 |
| 514 |
COMPLETED SUICIDE |
24 |
0.0003 |
| 515 |
HYPERTENSION |
61 |
0.0003 |
| 516 |
TENDERNESS |
3 |
0.0003 |
| 517 |
FORMICATION |
2 |
0.0003 |
| 518 |
EOSINOPHILIA |
5 |
0.0003 |
| 519 |
DIVERTICULUM |
2 |
0.0003 |
| 520 |
METABOLIC ACIDOSIS |
9 |
0.0003 |
| 521 |
SEPSIS |
31 |
0.0003 |
| 522 |
ATRIAL FIBRILLATION |
27 |
0.0003 |
| 523 |
FAECES DISCOLOURED |
6 |
0.0003 |
| 524 |
PRODUCT DISPENSING ERROR |
6 |
0.0003 |
| 525 |
OESOPHAGITIS |
3 |
0.0003 |
| 526 |
CHOLELITHIASIS |
9 |
0.0003 |
| 527 |
RESPIRATORY FAILURE |
20 |
0.0003 |
| 528 |
MIGRAINE |
26 |
0.0003 |
| 529 |
ALCOHOL USE |
1 |
0.0003 |
| 530 |
TRANSAMINASES INCREASED |
6 |
0.0003 |
| 531 |
HEPATIC FAILURE |
8 |
0.0003 |
| 532 |
GASTRIC ULCER |
5 |
0.0003 |
| 533 |
DEVICE FAILURE |
4 |
0.0003 |
| 534 |
DIABETES MELLITUS |
20 |
0.0003 |
| 535 |
ACIDOSIS |
2 |
0.0003 |
| 536 |
PROCEDURAL COMPLICATION |
2 |
0.0003 |
| 537 |
HYPOKALAEMIA |
12 |
0.0003 |
| 538 |
METASTASES TO LUNG |
3 |
0.0003 |
| 539 |
APNOEA |
2 |
0.0003 |
| 540 |
PELVIC FRACTURE |
2 |
0.0003 |
| 541 |
SWELLING |
24 |
0.0003 |
| 542 |
PRODUCT ADMINISTRATION INTERRUPTED |
2 |
0.0003 |
| 543 |
ULCER |
4 |
0.0003 |
| 544 |
PRESCRIBED UNDERDOSE |
5 |
0.0003 |
| 545 |
CARDIAC FAILURE CONGESTIVE |
20 |
0.0002 |
| 546 |
NIGHT SWEATS |
8 |
0.0002 |
| 547 |
PRODUCT PHYSICAL ISSUE |
5 |
0.0002 |
| 548 |
CHILLS |
29 |
0.0002 |
| 549 |
PSORIATIC ARTHROPATHY |
10 |
0.0002 |
| 550 |
POST PROCEDURAL INFECTION |
2 |
0.0002 |
| 551 |
CYST |
3 |
0.0002 |
| 552 |
AORTIC DISSECTION |
1 |
0.0002 |
| 553 |
HEMIPLEGIA |
2 |
0.0002 |
| 554 |
SYNCOPE |
24 |
0.0002 |
| 555 |
URINARY RETENTION |
8 |
0.0002 |
| 556 |
FACIAL PARALYSIS |
2 |
0.0002 |
| 557 |
INCORRECT DOSE ADMINISTERED BY DEVICE |
6 |
0.0002 |
| 558 |
GASTRITIS |
6 |
0.0002 |
| 559 |
GROIN PAIN |
2 |
0.0002 |
| 560 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
4 |
0.0002 |
| 561 |
PURPURA |
2 |
0.0002 |
| 562 |
LIVER DISORDER |
10 |
0.0002 |
| 563 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
16 |
0.0002 |
| 564 |
CARDIAC DISORDER |
21 |
0.0002 |
| 565 |
FACIAL PAIN |
2 |
0.0002 |
| 566 |
PRODUCT TASTE ABNORMAL |
3 |
0.0002 |
| 567 |
CHROMATURIA |
5 |
0.0002 |
| 568 |
BLINDNESS |
9 |
0.0002 |
| 569 |
PALLOR |
6 |
0.0002 |
| 570 |
BLOOD THYROID STIMULATING HORMONE DECREASED |
1 |
0.0002 |
| 571 |
HEPATIC ENZYME INCREASED |
15 |
0.0002 |
| 572 |
BLOOD PRESSURE SYSTOLIC DECREASED |
1 |
0.0002 |
| 573 |
PERIPHERAL COLDNESS |
3 |
0.0002 |
| 574 |
RENAL FAILURE |
29 |
0.0002 |
| 575 |
BRAIN NEOPLASM |
2 |
0.0002 |
| 576 |
ANAPHYLACTIC REACTION |
12 |
0.0002 |
| 577 |
BLOOD CHOLESTEROL ABNORMAL |
1 |
0.0002 |
| 578 |
ORAL DISCOMFORT |
3 |
0.0002 |
| 579 |
ANAEMIA |
41 |
0.0002 |
| 580 |
ERYTHEMA MULTIFORME |
2 |
0.0002 |
| 581 |
HAEMOGLOBIN DECREASED |
22 |
0.0002 |
| 582 |
MIDDLE INSOMNIA |
4 |
0.0002 |
| 583 |
APPENDICITIS |
2 |
0.0002 |
| 584 |
FLANK PAIN |
2 |
0.0002 |
| 585 |
PHOTOPHOBIA |
4 |
0.0002 |
| 586 |
DYSARTHRIA |
8 |
0.0002 |
| 587 |
DYSPNOEA EXERTIONAL |
8 |
0.0002 |
| 588 |
RENAL FAILURE ACUTE |
9 |
0.0002 |
| 589 |
SEASONAL ALLERGY |
3 |
0.0002 |
| 590 |
BRONCHOSPASM |
3 |
0.0002 |
| 591 |
RED BLOOD CELL COUNT DECREASED |
6 |
0.0002 |
| 592 |
RECALLED PRODUCT ADMINISTERED |
2 |
0.0002 |
| 593 |
HYPOTENSION |
42 |
0.0002 |
| 594 |
GAIT DISTURBANCE |
40 |
0.0002 |
| 595 |
LETHARGY |
12 |
0.0002 |
| 596 |
DYSPNOEA |
118 |
0.0002 |
| 597 |
POST PROCEDURAL COMPLICATION |
4 |
0.0002 |
| 598 |
DIZZINESS POSTURAL |
2 |
0.0002 |
| 599 |
INFLAMMATORY BOWEL DISEASE |
2 |
0.0002 |
| 600 |
PHARYNGEAL SWELLING |
2 |
0.0002 |
| 601 |
RENAL TUBULAR NECROSIS |
2 |
0.0002 |
| 602 |
ASTHMA |
23 |
0.0002 |
| 603 |
MUSCULAR WEAKNESS |
23 |
0.0002 |
| 604 |
BURNING SENSATION |
14 |
0.0002 |
| 605 |
SPINAL FRACTURE |
4 |
0.0002 |
| 606 |
BRAIN INJURY |
2 |
0.0002 |
| 607 |
BLOOD COUNT ABNORMAL |
3 |
0.0002 |
| 608 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
7 |
0.0002 |
| 609 |
PLEURAL EFFUSION |
12 |
0.0002 |
| 610 |
MOTOR DYSFUNCTION |
2 |
0.0002 |
| 611 |
INJECTION SITE RASH |
6 |
0.0002 |
| 612 |
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION |
2 |
0.0002 |
| 613 |
ERECTILE DYSFUNCTION |
5 |
0.0002 |
| 614 |
HELICOBACTER INFECTION |
2 |
0.0002 |
| 615 |
DISEASE PROGRESSION |
23 |
0.0002 |
| 616 |
BENIGN PROSTATIC HYPERPLASIA |
1 |
0.0002 |
| 617 |
SKIN ULCER |
5 |
0.0002 |
| 618 |
BLOOD CHOLESTEROL INCREASED |
9 |
0.0002 |
| 619 |
APLASTIC ANAEMIA |
1 |
0.0002 |
| 620 |
PRODUCT ODOUR ABNORMAL |
2 |
0.0002 |
| 621 |
MUSCLE SPASMS |
35 |
0.0002 |
| 622 |
INJECTION SITE DISCOMFORT |
2 |
0.0002 |
| 623 |
RASH ERYTHEMATOUS |
9 |
0.0002 |
| 624 |
ABSCESS |
3 |
0.0002 |
| 625 |
HYPOTHYROIDISM |
6 |
0.0002 |
| 626 |
HOT FLUSH |
14 |
0.0002 |
| 627 |
BLOOD POTASSIUM INCREASED |
3 |
0.0002 |
| 628 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
4 |
0.0002 |
| 629 |
SLEEP DISORDER |
13 |
0.0002 |
| 630 |
GASTROINTESTINAL PAIN |
2 |
0.0002 |
| 631 |
TOOTH FRACTURE |
2 |
0.0002 |
| 632 |
TOOTH DISORDER |
4 |
0.0002 |
| 633 |
HYPERTENSIVE CRISIS |
2 |
0.0002 |
| 634 |
MALNUTRITION |
2 |
0.0002 |
| 635 |
NEPHROPATHY TOXIC |
2 |
0.0002 |
| 636 |
INTESTINAL PERFORATION |
2 |
0.0002 |
| 637 |
FISTULA |
2 |
0.0002 |
| 638 |
BLOOD PRESSURE INCREASED |
27 |
0.0002 |
| 639 |
FLATULENCE |
10 |
0.0002 |
| 640 |
DRUG INTOLERANCE |
17 |
0.0002 |
| 641 |
BLOOD URIC ACID INCREASED |
1 |
0.0002 |
| 642 |
PERICARDIAL EFFUSION |
4 |
0.0002 |
| 643 |
LOCAL SWELLING |
3 |
0.0002 |
| 644 |
PARAESTHESIA |
27 |
0.0002 |
| 645 |
HEART RATE DECREASED |
6 |
0.0002 |
| 646 |
SPLENOMEGALY |
2 |
0.0002 |
| 647 |
BLOOD TRIGLYCERIDES INCREASED |
3 |
0.0002 |
| 648 |
PAIN IN EXTREMITY |
50 |
0.0002 |
| 649 |
BRADYKINESIA |
1 |
0.0002 |
| 650 |
COVID-19 PNEUMONIA |
2 |
0.0002 |
| 651 |
DRUG ERUPTION |
3 |
0.0002 |
| 652 |
DIZZINESS |
84 |
0.0002 |
| 653 |
COMA |
8 |
0.0002 |
| 654 |
CHOLECYSTITIS |
2 |
0.0002 |
| 655 |
CARDIO-RESPIRATORY ARREST |
7 |
0.0002 |
| 656 |
GOUT |
3 |
0.0002 |
| 657 |
RESPIRATORY DISORDER |
5 |
0.0002 |
| 658 |
MOBILITY DECREASED |
12 |
0.0002 |
| 659 |
LEUKOCYTOSIS |
3 |
0.0002 |
| 660 |
NOCTURIA |
2 |
0.0002 |
| 661 |
CEREBRAL INFARCTION |
4 |
0.0002 |
| 662 |
CYTOPENIA |
2 |
0.0002 |
| 663 |
LIVER INJURY |
4 |
0.0002 |
| 664 |
ABDOMINAL DISTENSION |
17 |
0.0002 |
| 665 |
BLOOD GLUCOSE ABNORMAL |
3 |
0.0002 |
| 666 |
TENDON RUPTURE |
2 |
0.0002 |
| 667 |
GASTROOESOPHAGEAL REFLUX DISEASE |
13 |
0.0002 |
| 668 |
ILEUS |
2 |
0.0002 |
| 669 |
SWOLLEN TONGUE |
5 |
0.0002 |
| 670 |
INJECTION SITE DISCOLOURATION |
2 |
0.0002 |
| 671 |
TUBULOINTERSTITIAL NEPHRITIS |
3 |
0.0002 |
| 672 |
HYPONATRAEMIA |
9 |
0.0002 |
| 673 |
BLEPHAROSPASM |
1 |
0.0002 |
| 674 |
ABDOMINAL PAIN LOWER |
4 |
0.0002 |
| 675 |
NEUROPATHY PERIPHERAL |
15 |
0.0002 |
| 676 |
THERAPY NON-RESPONDER |
7 |
0.0002 |
| 677 |
RASH GENERALISED |
4 |
0.0002 |
| 678 |
THERAPY INTERRUPTED |
11 |
0.0002 |
| 679 |
DEEP VEIN THROMBOSIS |
10 |
0.0002 |
| 680 |
ORAL HERPES |
3 |
0.0002 |
| 681 |
SWELLING FACE |
10 |
0.0002 |
| 682 |
MUSCULOSKELETAL PAIN |
8 |
0.0002 |
| 683 |
ANHEDONIA |
4 |
0.0002 |
| 684 |
THROMBOCYTOPENIA |
17 |
0.0002 |
| 685 |
ORAL CANDIDIASIS |
2 |
0.0002 |
| 686 |
PULMONARY CONGESTION |
2 |
0.0002 |
| 687 |
DISORIENTATION |
6 |
0.0002 |
| 688 |
HAEMATOCRIT DECREASED |
3 |
0.0002 |
| 689 |
MALIGNANT MELANOMA |
2 |
0.0001 |
| 690 |
ASTHENIA |
56 |
0.0001 |
| 691 |
BRONCHIECTASIS |
1 |
0.0001 |
| 692 |
LOSS OF CONSCIOUSNESS |
19 |
0.0001 |
| 693 |
TOXICITY TO VARIOUS AGENTS |
25 |
0.0001 |
| 694 |
SINUS CONGESTION |
2 |
0.0001 |
| 695 |
ARRHYTHMIA |
7 |
0.0001 |
| 696 |
SEIZURE |
17 |
0.0001 |
| 697 |
HYPOAESTHESIA |
22 |
0.0001 |
| 698 |
FEELING HOT |
9 |
0.0001 |
| 699 |
ABNORMAL LOSS OF WEIGHT |
1 |
0.0001 |
| 700 |
ALANINE AMINOTRANSFERASE INCREASED |
9 |
0.0001 |
| 701 |
TACHYCARDIA |
13 |
0.0001 |
| 702 |
ABNORMAL DREAMS |
4 |
0.0001 |
| 703 |
DELIRIUM |
5 |
0.0001 |
| 704 |
MASS |
2 |
0.0001 |
| 705 |
RENAL IMPAIRMENT |
12 |
0.0001 |
| 706 |
CARPAL TUNNEL SYNDROME |
2 |
0.0001 |
| 707 |
HYPOXIA |
5 |
0.0001 |
| 708 |
OSTEOARTHRITIS |
6 |
0.0001 |
| 709 |
EATING DISORDER |
3 |
0.0001 |
| 710 |
ABDOMINAL PAIN UPPER |
29 |
0.0001 |
| 711 |
SINUS TACHYCARDIA |
2 |
0.0001 |
| 712 |
RETCHING |
3 |
0.0001 |
| 713 |
URINARY TRACT INFECTION |
24 |
0.0001 |
| 714 |
POOR QUALITY SLEEP |
3 |
0.0001 |
| 715 |
PRODUCT SUBSTITUTION ISSUE |
8 |
0.0001 |
| 716 |
PRODUCT PRESCRIBING ISSUE |
3 |
0.0001 |
| 717 |
DRUG EFFECT INCOMPLETE |
5 |
0.0001 |
| 718 |
FLUID OVERLOAD |
2 |
0.0001 |
| 719 |
NEEDLE ISSUE |
4 |
0.0001 |
| 720 |
THERAPY CESSATION |
7 |
0.0001 |
| 721 |
NASAL CONGESTION |
8 |
0.0001 |
| 722 |
PNEUMONIA |
44 |
0.0001 |
| 723 |
BLOOD PRESSURE DIASTOLIC DECREASED |
1 |
0.0001 |
| 724 |
ARTHROPOD BITE |
1 |
0.0001 |
| 725 |
IMMUNODEFICIENCY |
2 |
0.0001 |
| 726 |
BACK PAIN |
31 |
0.0001 |
| 727 |
BLOOD POTASSIUM DECREASED |
4 |
0.0001 |
| 728 |
BREAST TENDERNESS |
1 |
0.0001 |
| 729 |
APHASIA |
4 |
0.0001 |
| 730 |
DEPRESSED MOOD |
7 |
0.0001 |
| 731 |
ASPARTATE AMINOTRANSFERASE INCREASED |
7 |
0.0001 |
| 732 |
AORTIC ANEURYSM |
1 |
0.0001 |
| 733 |
ABDOMINAL DISCOMFORT |
22 |
0.0001 |
| 734 |
MUSCULOSKELETAL CHEST PAIN |
2 |
0.0001 |
| 735 |
PRODUCT USE IN UNAPPROVED INDICATION |
32 |
0.0001 |
| 736 |
RASH |
56 |
0.0001 |
| 737 |
BASAL CELL CARCINOMA |
2 |
0.0001 |
| 738 |
NAUSEA |
101 |
0.0001 |
| 739 |
PRODUCT USE COMPLAINT |
2 |
0.0001 |
| 740 |
DYSPHAGIA |
12 |
0.0001 |
| 741 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
5 |
0.0001 |
| 742 |
BLOOD ALBUMIN DECREASED |
1 |
0.0001 |
| 743 |
CYSTITIS |
4 |
0.0001 |
| 744 |
BLOOD PRESSURE FLUCTUATION |
3 |
0.0001 |
| 745 |
MUSCLE TIGHTNESS |
2 |
0.0001 |
| 746 |
OEDEMA PERIPHERAL |
15 |
0.0001 |
| 747 |
PRODUCT DOSE OMISSION |
8 |
0.0001 |
| 748 |
ABNORMAL FAECES |
1 |
0.0001 |
| 749 |
DYSPEPSIA |
12 |
0.0001 |
| 750 |
ABASIA |
3 |
0.0001 |
| 751 |
VOMITING |
57 |
0.0001 |
| 752 |
EXPIRED PRODUCT ADMINISTERED |
4 |
0.0001 |
| 753 |
LIP SWELLING |
4 |
0.0001 |
| 754 |
SKIN DISORDER |
4 |
0.0001 |
| 755 |
DYSPHONIA |
7 |
0.0001 |
| 756 |
PALPITATIONS |
14 |
0.0001 |
| 757 |
ATRIAL SEPTAL DEFECT |
1 |
0.0001 |
| 758 |
URTICARIA |
20 |
0.0001 |
| 759 |
CELLULITIS |
6 |
0.0001 |
| 760 |
GLYCOSYLATED HAEMOGLOBIN INCREASED |
3 |
0.0001 |
| 761 |
GASTRIC CANCER |
3 |
0.0001 |
| 762 |
CARDIOVASCULAR DISORDER |
3 |
0.0001 |
| 763 |
HYPOPHAGIA |
3 |
0.0001 |
| 764 |
GASTRIC DISORDER |
4 |
0.0001 |
| 765 |
ANAPHYLACTIC SHOCK |
3 |
0.0001 |
| 766 |
BLOOD MAGNESIUM DECREASED |
1 |
0.0001 |
| 767 |
CARDIAC MURMUR |
1 |
0.0001 |
| 768 |
ORTHOSTATIC HYPOTENSION |
2 |
0.0001 |
| 769 |
RASH MACULAR |
4 |
0.0001 |
| 770 |
NEUROTOXICITY |
2 |
0.0001 |
| 771 |
BLOOD CALCIUM INCREASED |
1 |
0.0001 |
| 772 |
DIARRHOEA |
73 |
0.0001 |
| 773 |
OFF LABEL USE |
99 |
0.0001 |
| 774 |
DIABETES MELLITUS INADEQUATE CONTROL |
2 |
0.0001 |
| 775 |
INJECTION SITE BRUISING |
9 |
0.0001 |
| 776 |
INJECTION SITE HAEMORRHAGE |
9 |
0.0001 |
| 777 |
GALLBLADDER DISORDER |
2 |
0.0001 |
| 778 |
THIRST |
2 |
0.0001 |
| 779 |
MALAISE |
49 |
0.0001 |
| 780 |
GASTROENTERITIS VIRAL |
2 |
0.0001 |
| 781 |
COUGH |
31 |
0.0001 |
| 782 |
RESPIRATORY DISTRESS |
3 |
0.0001 |
| 783 |
DYSURIA |
4 |
0.0001 |
| 784 |
PROCEDURAL PAIN |
3 |
0.0001 |
| 785 |
AMNESIA |
7 |
0.0001 |
| 786 |
ABDOMINAL PAIN |
25 |
0.0001 |
| 787 |
PANCYTOPENIA |
6 |
0.0001 |
| 788 |
BACTERIAL INFECTION |
2 |
0.0001 |
| 789 |
CEREBROVASCULAR ACCIDENT |
18 |
0.0001 |
| 790 |
DEPRESSION |
24 |
0.0001 |
| 791 |
INTENTIONAL DOSE OMISSION |
3 |
0.0001 |
| 792 |
INTERNATIONAL NORMALISED RATIO INCREASED |
3 |
0.0001 |
| 793 |
DISEASE RECURRENCE |
5 |
0.0001 |
| 794 |
INJECTION SITE PRURITUS |
7 |
0.0001 |
| 795 |
HERPES ZOSTER |
6 |
0.0001 |
| 796 |
INJECTION SITE SWELLING |
8 |
0.0001 |
| 797 |
WHITE BLOOD CELL COUNT INCREASED |
4 |
0.0001 |
| 798 |
BLOOD GLUCOSE DECREASED |
5 |
0.0001 |
| 799 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
5 |
0.0001 |
| 800 |
PYREXIA |
36 |
0.0001 |
| 801 |
WEIGHT DECREASED |
29 |
0.0001 |
| 802 |
GLAUCOMA |
2 |
0.0001 |
| 803 |
PRESCRIBED OVERDOSE |
2 |
0.0001 |
| 804 |
COVID-19 |
18 |
0.0001 |
| 805 |
HAEMORRHOIDS |
2 |
0.0001 |
| 806 |
CHOKING |
2 |
0.0001 |
| 807 |
HEADACHE |
64 |
0.0001 |
| 808 |
ASCITES |
3 |
0.0001 |
| 809 |
BODY TEMPERATURE DECREASED |
1 |
0.0001 |
| 810 |
URINARY INCONTINENCE |
3 |
0.0001 |
| 811 |
UPPER LIMB FRACTURE |
2 |
0.0001 |
| 812 |
DRY EYE |
5 |
0.0001 |
| 813 |
PSORIASIS |
13 |
0.0001 |
| 814 |
LACRIMATION INCREASED |
3 |
0.0001 |
| 815 |
FALL |
33 |
0.0001 |
| 816 |
FATIGUE |
77 |
0.0001 |
| 817 |
FLUSHING |
10 |
0.0001 |
| 818 |
DEHYDRATION |
13 |
0.0001 |
| 819 |
HYPERSENSITIVITY |
18 |
0.0001 |
| 820 |
ARTHRALGIA |
40 |
0.0001 |
| 821 |
PULMONARY HYPERTENSION |
2 |
0.0001 |
| 822 |
POLLAKIURIA |
4 |
0.0001 |
| 823 |
BLOOD GLUCOSE INCREASED |
18 |
0.0001 |
| 824 |
GENERAL PHYSICAL HEALTH DETERIORATION |
11 |
0.0001 |
| 825 |
HEAD INJURY |
3 |
0.0001 |
| 826 |
BREAST PAIN |
1 |
0.0001 |
| 827 |
DRUG INEFFECTIVE |
123 |
0.0001 |
| 828 |
ALTERED STATE OF CONSCIOUSNESS |
2 |
0.0001 |
| 829 |
BLOOD CREATININE INCREASED |
6 |
0.0001 |
| 830 |
CONSTIPATION |
20 |
0.0001 |
| 831 |
CLOSTRIDIUM DIFFICILE INFECTION |
2 |
0.0001 |
| 832 |
INTENTIONAL PRODUCT USE ISSUE |
8 |
0.0001 |
| 833 |
ASPIRATION |
1 |
0.0001 |
| 834 |
BLOOD GLUCOSE FLUCTUATION |
1 |
0.0001 |
| 835 |
BLOOD PRESSURE DECREASED |
6 |
0.0001 |
| 836 |
MEDICATION ERROR |
5 |
0.0001 |
| 837 |
INFLUENZA |
10 |
0.0001 |
| 838 |
THERAPEUTIC RESPONSE UNEXPECTED |
4 |
0.0001 |
| 839 |
THROAT IRRITATION |
4 |
0.0001 |
| 840 |
BLISTER |
5 |
0.0001 |
| 841 |
PANCREATITIS ACUTE |
2 |
0.0001 |
| 842 |
OXYGEN SATURATION DECREASED |
5 |
0.0001 |
| 843 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
3 |
0.0001 |
| 844 |
SINUSITIS |
9 |
0.0001 |
| 845 |
SUICIDAL IDEATION |
8 |
0.0001 |
| 846 |
ILLNESS |
9 |
0.0001 |
| 847 |
NEPHROLITHIASIS |
4 |
0.0001 |
| 848 |
TINNITUS |
4 |
0.0001 |
| 849 |
SHOCK |
2 |
0.0001 |
| 850 |
NASOPHARYNGITIS |
16 |
0.0001 |
| 851 |
NIGHTMARE |
3 |
0.0001 |
| 852 |
CONFUSIONAL STATE |
14 |
0.0001 |
| 853 |
OROPHARYNGEAL PAIN |
8 |
0.0001 |
| 854 |
PAIN |
53 |
0.0001 |
| 855 |
PRODUCT DOSE OMISSION ISSUE |
25 |
0.0001 |
| 856 |
TREATMENT FAILURE |
7 |
0.0001 |
| 857 |
WHEEZING |
5 |
0.0001 |
| 858 |
ATAXIA |
1 |
0.0001 |
| 859 |
FEELING ABNORMAL |
20 |
0.0001 |
| 860 |
BURSITIS |
1 |
0.0001 |
| 861 |
HYPERGLYCAEMIA |
3 |
0.0001 |
| 862 |
CONDITION AGGRAVATED |
25 |
0.0001 |
| 863 |
AGITATION |
6 |
0.0001 |
| 864 |
ENCEPHALOPATHY |
2 |
0.0001 |
| 865 |
CARDIOMEGALY |
1 |
0.0001 |
| 866 |
BALANCE DISORDER |
7 |
0.0001 |
| 867 |
ABNORMAL WEIGHT GAIN |
1 |
0.0001 |
| 868 |
HEART RATE INCREASED |
8 |
0.0001 |
| 869 |
EYE SWELLING |
3 |
0.0001 |
| 870 |
MEMORY IMPAIRMENT |
11 |
0.0001 |
| 871 |
HEPATITIS |
2 |
0.0001 |
| 872 |
ADVERSE DRUG REACTION |
7 |
0.0001 |
| 873 |
PERIPHERAL SWELLING |
12 |
0.0001 |
| 874 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
14 |
0.0001 |
| 875 |
RHINORRHOEA |
5 |
0.0001 |
| 876 |
RESPIRATORY TRACT INFECTION |
2 |
0.0001 |
| 877 |
ARTHRITIS |
6 |
0.0001 |
| 878 |
ANKYLOSING SPONDYLITIS |
1 |
0.0001 |
| 879 |
PULMONARY EMBOLISM |
7 |
0.0001 |
| 880 |
ERYTHEMA |
15 |
0.0001 |
| 881 |
INFLUENZA LIKE ILLNESS |
6 |
0.0001 |
| 882 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
4 |
0.0001 |
| 883 |
APHONIA |
1 |
0.0001 |
| 884 |
BLINDNESS UNILATERAL |
1 |
0.0001 |
| 885 |
CONVULSION |
4 |
0.0001 |
| 886 |
PRODUCT USE ISSUE |
13 |
0.0001 |
| 887 |
VAGINAL HAEMORRHAGE |
3 |
0.0001 |
| 888 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
14 |
0.0001 |
| 889 |
DECREASED APPETITE |
16 |
0.0001 |
| 890 |
DYSSTASIA |
2 |
0.0001 |
| 891 |
PRURITUS |
26 |
0.0001 |
| 892 |
BRONCHITIS |
5 |
0.0001 |
| 893 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
3 |
0.0001 |
| 894 |
HALLUCINATION |
5 |
0.0001 |
| 895 |
STOMATITIS |
4 |
0.0001 |
| 896 |
PLATELET COUNT DECREASED |
7 |
0.0001 |
| 897 |
LIMB DISCOMFORT |
2 |
0.0001 |
| 898 |
NERVOUS SYSTEM DISORDER |
2 |
0.0001 |
| 899 |
BRAIN FOG |
1 |
0.0001 |
| 900 |
PRODUCTIVE COUGH |
3 |
0.0001 |
| 901 |
BACK DISORDER |
1 |
0.0001 |
| 902 |
LUNG DISORDER |
3 |
0.0001 |
| 903 |
EYE DISORDER |
2 |
0.0001 |
| 904 |
VISUAL ACUITY REDUCED |
2 |
0.0001 |
| 905 |
VIRAL INFECTION |
2 |
0.0001 |
| 906 |
FUNGAL INFECTION |
2 |
0.0001 |
| 907 |
AGGRESSION |
3 |
0.0001 |
| 908 |
HOSPITALISATION |
9 |
0.0001 |
| 909 |
VISION BLURRED |
8 |
0.0001 |
| 910 |
EMOTIONAL DISTRESS |
7 |
0.0001 |
| 911 |
NERVOUSNESS |
3 |
0.0001 |
| 912 |
MUSCULOSKELETAL STIFFNESS |
5 |
0.0001 |
| 913 |
AMENORRHOEA |
1 |
0.0001 |
| 914 |
DRUG WITHDRAWAL SYNDROME |
5 |
0.0001 |
| 915 |
INJECTION SITE ERYTHEMA |
7 |
0.0001 |
| 916 |
RASH PRURITIC |
3 |
0.0001 |
| 917 |
WHITE BLOOD CELL COUNT DECREASED |
6 |
0.0001 |
| 918 |
BONE DISORDER |
1 |
0.0001 |
| 919 |
RESTLESSNESS |
2 |
0.0001 |
| 920 |
TREMOR |
9 |
0.0001 |
| 921 |
INJECTION SITE MASS |
2 |
0.0001 |
| 922 |
AGRANULOCYTOSIS |
1 |
0.0001 |
| 923 |
NECK PAIN |
3 |
0.0001 |
| 924 |
WEIGHT INCREASED |
12 |
0.0001 |
| 925 |
COLITIS |
2 |
0.0001 |
| 926 |
ANXIETY |
15 |
0.0001 |
| 927 |
PRODUCT QUALITY ISSUE |
7 |
0.0001 |
| 928 |
BONE PAIN |
3 |
0.0001 |
| 929 |
DEATH |
44 |
0.0001 |
| 930 |
CATARACT |
3 |
0.0001 |
| 931 |
IRRITABILITY |
3 |
0.0000 |
| 932 |
DRY MOUTH |
4 |
0.0000 |
| 933 |
DEVICE BREAKAGE |
2 |
0.0000 |
| 934 |
BONE MARROW FAILURE |
1 |
0.0000 |
| 935 |
BODY TEMPERATURE INCREASED |
1 |
0.0000 |
| 936 |
OSTEOPOROSIS |
2 |
0.0000 |
| 937 |
ACCIDENTAL EXPOSURE TO PRODUCT |
5 |
0.0000 |
| 938 |
VISUAL IMPAIRMENT |
6 |
0.0000 |
| 939 |
ROAD TRAFFIC ACCIDENT |
2 |
0.0000 |
| 940 |
WITHDRAWAL SYNDROME |
2 |
0.0000 |
| 941 |
APPLICATION SITE PAIN |
1 |
0.0000 |
| 942 |
DEVICE DIFFICULT TO USE |
3 |
0.0000 |
| 943 |
INSOMNIA |
12 |
0.0000 |
| 944 |
GASTROINTESTINAL DISORDER |
4 |
0.0000 |
| 945 |
SKIN IRRITATION |
2 |
0.0000 |
| 946 |
SKIN DISCOLOURATION |
2 |
0.0000 |
| 947 |
ADVERSE EVENT |
4 |
0.0000 |
| 948 |
UPPER RESPIRATORY TRACT INFECTION |
2 |
0.0000 |
| 949 |
RENAL DISORDER |
2 |
0.0000 |
| 950 |
OCULAR HYPERAEMIA |
2 |
0.0000 |
| 951 |
INTERSTITIAL LUNG DISEASE |
2 |
0.0000 |
| 952 |
DYSGEUSIA |
3 |
0.0000 |
| 953 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
1 |
0.0000 |
| 954 |
LEUKOPENIA |
2 |
0.0000 |
| 955 |
INCORRECT DOSE ADMINISTERED |
9 |
0.0000 |
| 956 |
SPEECH DISORDER |
2 |
0.0000 |
| 957 |
APPLICATION SITE ERYTHEMA |
1 |
0.0000 |
| 958 |
DERMATITIS ATOPIC |
2 |
0.0000 |
| 959 |
PROSTATE CANCER |
3 |
0.0000 |
| 960 |
SKIN EXFOLIATION |
3 |
0.0000 |
| 961 |
EYE PAIN |
2 |
0.0000 |
| 962 |
RHEUMATOID ARTHRITIS |
4 |
0.0000 |
| 963 |
INTENTIONAL PRODUCT MISUSE |
3 |
0.0000 |
| 964 |
SURGERY |
2 |
0.0000 |
| 965 |
BLADDER CANCER |
2 |
0.0000 |
| 966 |
JOINT SWELLING |
4 |
0.0000 |
| 967 |
THERAPEUTIC RESPONSE DECREASED |
2 |
0.0000 |
| 968 |
ILL-DEFINED DISORDER |
2 |
0.0000 |
| 969 |
EXPOSURE DURING PREGNANCY |
2 |
0.0000 |
| 970 |
INFUSION RELATED REACTION |
2 |
0.0000 |
| 971 |
SOMNOLENCE |
6 |
0.0000 |
| 972 |
MALIGNANT NEOPLASM PROGRESSION |
3 |
0.0000 |
| 973 |
INJURY |
2 |
0.0000 |
| 974 |
INFECTION |
4 |
0.0000 |
| 975 |
UNDERDOSE |
2 |
0.0000 |
| 976 |
ACCIDENTAL OVERDOSE |
1 |
0.0000 |
| 977 |
ACNE |
2 |
0.0000 |
| 978 |
INJECTION SITE PAIN |
8 |
0.0000 |
| 979 |
DRUG DOSE OMISSION BY DEVICE |
2 |
0.0000 |
| 980 |
ABORTION SPONTANEOUS |
1 |
0.0000 |
| 981 |
DRUG DOSE OMISSION |
4 |
0.0000 |
| 982 |
PRODUCT STORAGE ERROR |
2 |
0.0000 |
| 983 |
MATERNAL EXPOSURE DURING PREGNANCY |
2 |
0.0000 |
| 984 |
DEVICE ISSUE |
2 |
0.0000 |
| 985 |
NEUTROPENIA |
3 |
0.0000 |
| 986 |
BREAST CANCER |
2 |
0.0000 |
| 987 |
OVERDOSE |
4 |
0.0000 |
| 988 |
ARTHROPATHY |
1 |
0.0000 |
| 989 |
NO ADVERSE EVENT |
3 |
0.0000 |
| 990 |
DRY SKIN |
2 |
0.0000 |
| 991 |
ALOPECIA |
1 |
0.0000 |